UBS Group’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,869,063
| Closed | -$23.3M | – | 7571 |
|
|
2019
Q4 | $23.3M | Sell |
3,869,063
-2,064,770
| -35% | -$12.5M | 0.01% | 987 |
|
|
2019
Q3 | $21.4M | Buy |
5,933,833
+358,305
| +6% | +$1.29M | 0.01% | 938 |
|
|
2019
Q2 | $14.9M | Buy |
5,575,528
+1,824,534
| +49% | +$4.89M | 0.01% | 1146 |
|
|
2019
Q1 | $11.1M | Buy |
3,750,994
+2,372,427
| +172% | +$7.02M | ﹤0.01% | 1294 |
|
|
2018
Q4 | $2.19M | Buy |
1,378,567
+1,312,467
| +1,986% | +$2.09M | ﹤0.01% | 2364 |
|
|
2018
Q3 | $243K | Buy |
66,100
+33,640
| +104% | +$124K | ﹤0.01% | 4106 |
|
|
2018
Q2 | $92K | Sell |
32,460
-272,677
| -89% | -$773K | ﹤0.01% | 4624 |
|
|
2018
Q1 | $1.13M | Buy |
305,137
+207,824
| +214% | +$771K | ﹤0.01% | 2938 |
|
|
2017
Q4 | $280K | Sell |
97,313
-31,801
| -25% | -$91.5K | ﹤0.01% | 3810 |
|
|
2017
Q3 | $580K | Buy |
129,114
+44,006
| +52% | +$198K | ﹤0.01% | 3357 |
|
|
2017
Q2 | $391K | Sell |
85,108
-14,309
| -14% | -$65.7K | ﹤0.01% | 3503 |
|
|
2017
Q1 | $419K | Sell |
99,417
-95,600
| -49% | -$403K | ﹤0.01% | 3393 |
|
|
2016
Q4 | $806K | Buy |
195,017
+42,347
| +28% | +$175K | ﹤0.01% | 2979 |
|
|
2016
Q3 | $1.24M | Sell |
152,670
-40,701
| -21% | -$330K | ﹤0.01% | 2606 |
|
|
2016
Q2 | $1.51M | Buy |
193,371
+10,109
| +6% | +$78.8K | ﹤0.01% | 2400 |
|
|
2016
Q1 | $1.42M | Sell |
183,262
-248,075
| -58% | -$1.92M | ﹤0.01% | 2407 |
|
|
2015
Q4 | $4.66M | Buy |
431,337
+194,410
| +82% | +$2.1M | ﹤0.01% | 1575 |
|
|
2015
Q3 | $1.64M | Buy |
236,927
+381
| +0.2% | +$2.63K | ﹤0.01% | 2285 |
|
|
2015
Q2 | $2.1M | Buy |
236,546
+11,417
| +5% | +$101K | ﹤0.01% | 2267 |
|
|
2015
Q1 | $2.22M | Buy |
225,129
+82,052
| +57% | +$809K | ﹤0.01% | 2217 |
|
|
2014
Q4 | $1.75M | Buy |
+143,077
| New | +$1.75M | ﹤0.01% | 2338 |
|